PDS Biotechnology Corp (PDSB)
3.82
+0.10
(+2.69%)
USD |
NASDAQ |
May 03, 11:34
PDS Biotechnology Market Cap: 140.11M for May 3, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 02, 2024 | 136.45M |
| May 01, 2024 | 132.41M |
| April 30, 2024 | 122.88M |
| April 29, 2024 | 124.34M |
| April 26, 2024 | 119.94M |
| April 25, 2024 | 119.57M |
| April 24, 2024 | 119.21M |
| April 23, 2024 | 117.37M |
| April 22, 2024 | 109.67M |
| April 19, 2024 | 97.02M |
| April 18, 2024 | 106.37M |
| April 17, 2024 | 99.77M |
| April 16, 2024 | 102.70M |
| April 15, 2024 | 103.44M |
| April 12, 2024 | 117.01M |
| April 11, 2024 | 123.61M |
| April 10, 2024 | 115.54M |
| April 09, 2024 | 119.94M |
| April 08, 2024 | 121.41M |
| April 05, 2024 | 118.47M |
| April 04, 2024 | 120.67M |
| April 03, 2024 | 134.98M |
| April 02, 2024 | 136.45M |
| April 01, 2024 | 147.45M |
| March 28, 2024 | 145.25M |
| Date | Value |
|---|---|
| March 27, 2024 | 141.22M |
| March 26, 2024 | 164.32M |
| March 25, 2024 | 173.49M |
| March 22, 2024 | 169.46M |
| March 21, 2024 | 179.00M |
| March 20, 2024 | 159.18M |
| March 19, 2024 | 155.21M |
| March 18, 2024 | 157.36M |
| March 15, 2024 | 162.16M |
| March 14, 2024 | 158.36M |
| March 13, 2024 | 157.20M |
| March 12, 2024 | 153.06M |
| March 11, 2024 | 164.15M |
| March 08, 2024 | 180.70M |
| March 07, 2024 | 192.61M |
| March 06, 2024 | 199.89M |
| March 05, 2024 | 191.95M |
| March 04, 2024 | 204.19M |
| March 01, 2024 | 218.09M |
| February 29, 2024 | 218.09M |
| February 28, 2024 | 194.26M |
| February 27, 2024 | 201.88M |
| February 26, 2024 | 183.34M |
| February 23, 2024 | 179.37M |
| February 22, 2024 | 177.06M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
6.971M
Minimum
Feb 12 2020
485.48M
Maximum
Sep 23 2021
137.72M
Average
130.97M
Median
Market Cap Benchmarks
| Syros Pharmaceuticals Inc | 136.24M |
| PAVmed Inc | 19.72M |
| Altimmune Inc | 513.99M |
| Regeneron Pharmaceuticals Inc | 103.26B |
| iBio Inc | 7.178M |
Market Cap Related Metrics
| Price to Book Value | 5.362 |
| Price | 3.82 |
| Earnings Yield | -36.39% |